Nordion Statement on Voluntary Disclosure
13:12 EDT 8 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
OTTAWA, Aug. 8, 2012 /PRNewswire/ - Nordion Inc. (TSX: NDN) (NYSE: NDZ), a
leading provider of products and services for the prevention, diagnosis
and treatment of disease, today disclosed that it is conducting an
internal inquiry and investigation of ...
Other Sources for this Article
More From BioPortfolio on "Nordion Statement on Voluntary Disclosure"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
